Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nordic Haemostasis AB
AB
Active
Org 5568530132
Vildmannavägen 1, 903 47
Umeå
Manufacture of other chemical products n.e.c.
·
NACE 2059
Est. 2011 · 15 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of other chemical products n.e.c.
/
Nordic Haemostasis AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2020: 1M
1M
2020
2021: 2M (+100% vs 2020)
2M
+100%
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
EBITDA
SEK millions
2M
2M
1M
1M
0M
2020: 0M
0M
2020
2021: 1M
1M
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 2M
2M
2023
2024: 1M (-50% vs 2023)
1M
-50%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
1 662
2 133
1 617
1 892
1 297
Staff expenses
—
—
—
—
—
EBITDA
1 053
1 509
27
766
61
Depreciation & amort.
−20
−20
−1
−0
−0
EBIT
1 033
1 489
26
766
61
Net financials
27
−2
−1
−2
—
Profit before tax
10
7
25
764
61
Tax
−1
−2
−8
−164
−15
Net profit
9
5
17
600
46
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
792
1 323
863
1 044
594
Equity
741
732
727
770
320
Long-term debt
0
0
0
0
0
Short-term debt
51
591
136
274
274
Total debt
51
591
136
274
274
Financial ratios
5-year trend
EBITDA margin
63,4 %
This company
15,8 %
Market median
This company
Market median
301% above market
2020
2024
Equity ratio
93,6 %
This company
38,2 %
Market median
This company
Market median
145% above market
2020
2024
Return on equity
1,2 %
This company
18,4 %
Market median
This company
Market median
93% below market
2020
2024
Net profit margin
0,5 %
This company
8,1 %
Market median
This company
Market median
94% below market
2020
2024
Asset turnover
2,10×
This company
1,12×
Market median
This company
Market median
87% above market
2020
2024
Debt / equity
0,07×
This company
0,62×
Market median
This company
Market median
89% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Nordic Haemostasis AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
